irinotecan has been researched along with Meningeal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fastner, G; Greil, R; Huemer, F; Kleindienst, W; Machegger, L; Romagna, A; Schwartz, C; Weis, S; Weiss, L; Winkler, PA | 1 |
| Ilson, DH; Krol, G; Ku, GY | 1 |
2 other study(ies) available for irinotecan and Meningeal Neoplasms
| Article | Year |
|---|---|
Extensive Leptomeningeal Intracranial and Spinal Metastases in a Patient with a Supratentorial Glioblastoma Multiforme, IDH-Wildtype.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Chemoradiotherapy, Adjuvant; DNA Mutational Analysis; Glioblastoma; High-Throughput Nucleotide Sequencing; Humans; Irinotecan; Isocitrate Dehydrogenase; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Microsatellite Instability; Middle Aged; Neurosurgical Procedures; Palliative Care; Radiotherapy; Sequence Analysis, DNA; Supratentorial Neoplasms; Temozolomide | 2018 |
Successful treatment of leptomeningeal disease in colorectal cancer with a regimen of bevacizumab, temozolomide, and irinotecan.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colorectal Neoplasms; Dacarbazine; Humans; Irinotecan; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Middle Aged; Temozolomide; Treatment Outcome | 2007 |